ARCHIE GRUBB CURRENT CLASS ACTION LITIGATION
LARRY GOLSTON SEXUAL HARASSMENT
LANCE GOULD WHISTLEBLOWER LITIGATION
ALI HAWTHORNE Pharmaceutical Fraud & Attorney General Litigation
AUTO CLASS ACTIONS Defective airbags Defective Bucket Trucks Steel arm fails to meet specification 2014-2016 Pickups and SUVS 2.0 Settled 3.0 Diesel Settled 3.0 Gas ongoing F-150 Brake Failures in 2013-2018 models Sudden Unintended Acceleration
ANTITRUST CLASS ACTIONS
Verbal Sexual Harassment 34 77 Unwelcome Sexual Touching 17 51 Cyber Sexual Harrassment 22 41 Being Physically Followed 12 34 Unwanted Genital Flashing 12 30 Sexual Assault 7 27 Women Men
Assault Battery Invasion of Privacy False Imprisonment Negligent and/or Wanton Supervision Intentional Infliction of Emotional Distress
Basic Issues in Sexual Harassment Litigation Two types of Harassment: (1) Tangible Employment Action (2) No Adverse Tangible Employment Action. Constructive discharge: Working conditions were so intolerable;a reasonable person in employee s position would be compelled to resign. Retaliation:(i) An employee who files an administrative charge of discrimination or otherwise participates in an administrative proceeding or (ii) who otherwise opposes discrimination.
WHISTLEBLOWERS
Who is a Whistleblower Whistleblowers are the most essential element to discovering and exposing fraudulent activity against our Government. A whistleblower, also known as a relator, must be a person with first-hand knowledge of fraud or other wrongdoing. A whistleblower may sue on behalf of the Government when she witnesses fraud, waste, and/or abuse in Government programs.
IDENTIFYING A WHISTLEBLOWER Agencies Industries
Whistleblower Recoveries 2017 the U.S. Government recovered $3.5 billion from FCA lawsuits $2.5 billion came from the health care industry $35 billion recovered under the FCA since 2009
IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ALABAMA SOUTHERN DIVISION BARRY TAUL, ex rel., UNITED STATES OF AMERICA, Plaintiff, v. NAGEL ENTERPRISES, INC., et al., Defendants. ) ) ) ) ) ) ) ) ) ) ) Case No.: 2:14-CV-0061-VEH Pursuant to 31 U.S.C. 3730(d)(2), and because the United States government did not proceed in this action, Plaintiff Barry Taul is entitled to 27.5% (twenty-seven and one half percent) of the proceeds of this lawsuit. In total, the Court ENTERS a judgment in the total amount of $14,708,630.06 (fourteen million seven hundred eight thousand six hundred thirty dollars and six cents) against both Defendants, jointly and severally.
Pharmaceutical Litigation Antitrust Fraudulent Price Reporting Fraudulent Reporting of FDA Approval Status False Representations As To Safety & Effectiveness Unlawful Retention of Rebates & Recoupments
Attorney General Litigation The Center for Medicare and Medicaid Services estimates prescription drug spending will increase an average of 3.6% per year over the 2016-2025 time period.
Attorney General Litigation Antitrust & Fraudulent Price Reporting Usual and Customary Litigation Fraudulent Reporting of FDA Approval Status Unapproved Drugs Litigation False Representations As To Safety & Effectiveness GranuFlo Litigation Actos Litigation Unlawful Retention of Rebates and Recoupments Investigation into hidden fees and retained recoupments
Attorney General Litigation Antitrust & Fraudulent Price Reporting Usual and Customary Litigation Fraudulent Reporting of FDA Approval Status Unapproved Drugs Litigation False Representations As To Safety & Effectiveness GranuFlo Litigation Actos Litigation Unlawful Retention of Rebates and Recoupments Investigation into hidden fees and retained recoupments
Attorney General Litigation Antitrust & Fraudulent Price Reporting Usual and Customary Litigation Fraudulent Reporting of FDA Approval Status Unapproved Drugs Litigation False Representations As To Safety & Effectiveness GranuFlo Litigation Actos Litigation Unlawful Retention of Rebates and Recoupments Investigation into hidden fees and retained recoupments
Attorney General Litigation Antitrust & Fraudulent Price Reporting Usual and Customary Litigation Fraudulent Reporting of FDA Approval Status Unapproved Drugs Litigation False Representations As To Safety & Effectiveness GranuFlo Litigation Actos Litigation Unlawful Retention of Rebates and Recoupments Investigation into hidden fees and retained recoupments
Attorney General Litigation Antitrust & Fraudulent Price Reporting Usual and Customary Litigation Fraudulent Reporting of FDA Approval Status Unapproved Drugs Litigation False Representations As To Safety & Effectiveness GranuFlo Litigation Actos Litigation Unlawful Retention of Rebates and Recoupments Investigation into hidden fees and retained recoupments
Attorney General Litigation Antitrust & Fraudulent Price Reporting Usual and Customary Litigation Fraudulent Reporting of FDA Approval Status Unapproved Drugs Litigation False Representations As To Safety & Effectiveness GranuFlo Litigation Actos Litigation Unlawful Retention of Rebates and Recoupments Investigation into hidden fees and retained recoupments
Potential Types of Plaintiffs 1. Individual Consumers 2. State Attorneys General 3. Municipalities 4. Self-Funded Healthcare Plans